Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy

Clinical trial NCT01652560 · UNKNOWN

Trial details

NCT number: NCT01652560
Sponsor: LiNanlin,Ph.D, Chief Physician,Clinical Professor
Status: UNKNOWN
Study type: OBSERVATIONAL

Breast Cancer Bevacizumab Neoadjuvant Chemotherapy Molecular Targeted Therapy

Start date: 2012-06-01
Primary completion: 2014-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.